Connect with us

Hi, what are you looking for?

Deluxe Investment Group – Investing and Stock NewsDeluxe Investment Group – Investing and Stock News

Stock

Amazon same-day prescription delivery expanding to nearly half of U.S. in 2025

Amazon plans to bring same-day prescription delivery to 20 more cities next year, the company said Wednesday, marking the latest phase of its push into health care.

As part of the expansion, which will make speedy medicine delivery available in nearly half of the U.S., Amazon said, it is embedding pharmacies in same-day delivery facilities often clustered around major metro areas. The company announced its plans during a press event at one of its warehouses near Nashville, Tennessee.

Amazon in March introduced same-day pharmacy delivery in New York and Los Angeles, after launching the service in Indianapolis, Miami, Phoenix, Seattle, and Austin, Texas. Some of the cities that will be added in 2025 include Boston, Dallas, Minneapolis, Philadelphia and San Diego.

The company has worked to accelerate medication deliveries. It’s been testing prescription delivery by drone in one Texas city. In most cases, the company said, when shoppers order same-day delivery of their medication by 4 p.m. they can receive it at home by 10 p.m.

The prescriptions are offered through Amazon Pharmacy, a section of its website and app that allows shoppers to order medication, with free delivery for Prime members. Launched in 2020, Amazon Pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack. The company in January said it had doubled the number of customers it serves in the past year, though it didn’t provide a specific number.

It faces competition from traditional pharmacies such as CVS and Walgreens, as well as other large retailers that offer pharmacy services, such as Walmart. Amazon said Wednesday it’s capitalizing on the care gaps created by the growing number of “pharmacy deserts” in the U.S., which can limit a patient’s access to medications and pharmacist care. Chain stores such as Walgreens and CVS have shuttered hundreds of locations recently as they struggle to maintain profitability.

Amazon’s online pharmacy is a part of the company’s multiyear effort to make inroads in the health-care industry. The company acquired primary care provider One Medical for roughly $3.9 billion in July 2022. It launched then shuttered its telehealth service, Amazon Care, along with a line of health and wellness devices.

This post appeared first on NBC NEWS

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!



    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    Florida Gov. Ron DeSantis (R) needs a massive infusion of cash in the next two months of the Republican presidential primary race to help...

    Editor's Pick

    ERP or Enterprise Resource Planning solutions help businesses of all sizes manage their daily business operations. First used in the 1990s, ERP systems have...

    Economy

    Amp’s 223.67% Leap: Analyzing the Sudden Spike The cryptocurrency community has recently been set abuzz by the phenomenal rise of Amp (AMP). Just in...

    Latest News

    The United States could be on track for a Joe Biden-Donald Trump rematch in 2024, but it’s the president’s son Hunter Biden who earned...

    Disclaimer: Deluxeinvestmentgroup.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 deluxeinvestmentgroup.com